Shoshana Shendelman
Shoshana Shendelman | |
|---|---|
| Alma mater | Columbia University |
| Known for | Founder of Applied Therapeutics |
| Website | https://drshendelman.com/ |
Shoshana Shendelman is an American scientist and founder of several biotech companies.[1] As of March 2025, Shendelman is the president of the biotech firms Retension Pharmaceuticals and Response Pharmaceuticals.[2]
Education
Shendelman obtained a BA in biochemistry from Brandeis University and an MA, MSc, and a PhD from the Columbia University College of Physicians and Surgeons where she wrote her dissertation on the molecular mechanisms of Parkinson’s Disease.[3]
Career
In 2008, Shendelman founded the life sciences consulting firm Clearpoint Strategy Group where she served as managing director for six years.[4] In 2016, Shendelman founded Applied Therapeutics, a biopharmaceutical company dedicated to creating treatments for rare diseases.[5] In 2024, Shendelman left the company after shareholders filed a class action lawsuit against her alleging securities fraud.[6][7][8]
In 2023, Shendelman joined the Trustees of Columbia University in the City of New York.[9]
References
- ^ "Shoshana Shendelman". Forbes. Retrieved July 7, 2025.
- ^ "Shoshana Shendelman | Office of the Secretary". secretary.columbia.edu. Retrieved July 7, 2025.
- ^ "Shoshana Shendelman | Office of the Secretary". secretary.columbia.edu. Retrieved July 7, 2025.
- ^ "Kikka Hanazawa and Shoshana Shendelman Join Trustees | Columbia Magazine". magazine.columbia.edu. Retrieved July 7, 2025.
- ^ Gilson, Grace (July 2, 2025). "House committee says acting Columbia president Claire Shipman suggested the ouster of a Jewish trustee". Jewish Telegraphic Agency. Retrieved July 8, 2025.
- ^ Walton, Meghnad Bose, Lara-Nour (May 27, 2025). "Columbia Trustee Got Sued for Securities Fraud — Then Left Her Pharma Firm Under a Cloud". The Intercept. Retrieved July 7, 2025.
{{cite web}}: CS1 maint: multiple names: authors list (link) - ^ Incorvaia, Darren (December 20, 2024). "After investors file lawsuit, Applied CEO steps down". www.fiercebiotech.com. Retrieved July 7, 2025.
- ^ Feuerstein, Adam (December 5, 2024). "Why Applied Therapeutics has a credibility problem". STAT. Retrieved July 8, 2025.
- ^ Pickering, Emily. "Trustee Shoshana Shendelman, VP&S '03, '04, '05, files to dismiss securities fraud lawsuit over her pharmaceutical company". Columbia Daily Spectator. Retrieved July 7, 2025.